Press Releases about Adc Therapeutics Sa
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
ADC Therapeutics to Participate in September Investor Conferences
September 05, 2023
From ADC Therapeutics SA
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
From ADC Therapeutics SA
Via GlobeNewswire
![](https://ml-eu.globenewswire.com/media/42234478-810e-48c2-aadd-36edac51810d/small/adct-4c-tm-png.png)
![](https://mms.businesswire.com/media/20230511005589/en/1791181/22/ADCT_4C_TM_%282%29.jpg)
![](https://mms.businesswire.com/media/20230510005088/en/1787905/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230509005395/en/1787197/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230502005198/en/1779379/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230315005747/en/1739598/22/ADCT_4C_TM_%282%29.jpg)
![](https://mms.businesswire.com/media/20230301005027/en/1722833/22/ADCT_4C_TM_%281%29.jpg)
![](https://mms.businesswire.com/media/20230228005143/en/1723575/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230221005330/en/1718064/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230202005500/en/1703865/22/ADCT_4C_TM.jpg)
ADC Therapeutics Announces Pricing of Underwritten Offering by a Selling Shareholder
February 02, 2023
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20230201005160/en/1701453/22/ADCT_Corporate_Final_4C.jpg)
ADC Therapeutics to Participate in February Investor Conferences
February 01, 2023
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20230104005240/en/1676033/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20230103005766/en/1675770/5/Mohamed-Zaki_social-web_72px.jpg)
ADC Therapeutics Appoints Mohamed Zaki as Chief Medical Officer
January 03, 2023
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20221220005787/en/1670496/22/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20221219005210/en/1668195/5/Jose_Carmona.jpg)
ADC Therapeutics Appoints Jose Carmona as Chief Financial Officer
December 19, 2022
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20221128005475/en/1647986/4/logo250.jpg)
![](https://mms.businesswire.com/media/20221108005150/en/1627941/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20221107005128/en/1626309/5/ADCT_4C_TM.jpg)
From ADC Therapeutics SA
Via Business Wire
![](https://mms.businesswire.com/media/20221102006135/en/1623798/5/ADCT_4C_TM.jpg)
![](https://mms.businesswire.com/media/20221102005939/en/1623167/4/IGM_biosciences.jpg)
![](https://ml.globenewswire.com/media/312125d7-48ef-48f1-aa8e-a7532c2f21e8/small/igm-logo-trademark-03-25-22-jpg.jpg)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.